Guttify: Building a Diagnostics-First Approach to Personalised Gut Health

Problem

Digestive concerns such as bloating, acidity, constipation and irregular bowel movements can have different underlying causes, but consumers often turn to generic remedies. Access to convenient gut-health screening and personalised guidance also remains limited. Guttify aims to bridge this gap through accessible testing and targeted nutritional solutions.

Product

Guttify offers the Gut Scan Kit, an at-home saliva-based screening product, alongside effervescent formulations such as Acid Ease, Digest Boost, Liver Lift and Apple Active. Its portfolio also includes Piles Pure and daily gut-care combinations. The company's longer-term science platform follows a test, interpret, intervene, track and learn approach to develop more personalised gut-health recommendations.

Proof

Guttify launched its Gut Scan Kit in 2025 and has developed a direct-to-consumer product portfolio addressing digestive wellness. Its official website lists multiple gut-health formulations, at-home screening products and expert consultation services. The company is also developing research capabilities around microbial signals, ingredient testing and real-world consumer outcomes.

Guttify operates as a gut-health brand under Lifechart and is associated with co-founders Mukul Shah and Mansi Sharma. The founding team is focused on combining modern formulation science, Ayurveda and accessible diagnostic solutions to build a consumer-focused gut-health ecosystem.

Purse

Guttify's parent company, Lifechart, raised a $500,000 seed round in October 2024, followed by a $360,000 extended seed round in May 2025, led by Prajay Advisors, the family office associated with Unichem Laboratories' founders. In February 2026, it reportedly secured another ₹4 crore in follow-on funding, taking cumulative funding beyond ₹10 crore.

Plan

Guttify is developing a broader diagnostics-led gut-health platform, with plans to strengthen at-home screening, microbial research and personalised nutritional interventions. Its expansion priorities include new formulations, improved diagnostic capabilities and wider distribution across Tier 1 and Tier 2 markets.

Why it matters:

Guttify is attempting to shift gut healthcare from symptom-based product purchases towards a diagnosis-first approach. By combining screening, nutritional science and personalised interventions, it is exploring an opportunity to make digestive wellness more measurable and accessible to Indian consumers.

FAST FACTS